About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Centre Hospitalier Régional et Universitaire de Lille
›
Top Articles
Centre Hospitalier Régional et Universitaire de Lille
(chru-lille.fr)
2.8K
(top 7%)
articles
78.6K
(top 6%)
citations
860
(top 6%)
★★
articles
20
(top 7%)
★★★
articles
2.4
(top 22%)
Avg IF
117
(top 6%)
H-Index
189
(top 6%)
G-Index
929
journals
Most Cited Articles of Centre Hospitalier Régional et Universitaire de Lille
Title
Journal
Year
Citations
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Science
2015
1.7K
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Lancet Oncology, The
2018
1.1K
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Lancet Neurology, The
2016
921
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
Lancet, The
2014
753
Fractal and multifractal analysis: a review
Medical Image Analysis
2009
592
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Lancet Oncology, The
2016
576
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study
Arthritis and Rheumatism
2005
526
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations
Nature Genetics
2009
521
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Leukemia
2010
505
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
Gastroenterology
2000
493
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses
Blood
2012
469
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed
Gastroenterology
2014
468
Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure
Circulation Research
2014
448
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped
Gastroenterology
2012
446
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Diabetologia
2020
442
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids
Hepatology
2007
441
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Immunological Reviews
2007
431
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Lancet Oncology, The
2019
425
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
JAMA - Journal of the American Medical Association
2014
405
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients
Medicine (United States)
2004
401
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial
Journal of Endovascular Therapy
2006
393
Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia
Ultrasound in Obstetrics and Gynecology
2007
376
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Immunity
2016
376
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
Leukemia
2011
369
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Lancet, The
2015
356
site/software ©
exaly
; All materials licenced under
CC by-SA
.